Tenaya Therapeutics
Biotechnology, 171 Oyster Pt BLVD, South San Francisco, California, 94080, United States, 51-200 Employees
Phone Number: 51********
Who is TENAYA THERAPEUTICS
Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the Universi...
Read More
-
Headquarters: 171 Oyster Pt BLVD, South San Francisco, California, 94080, United States
-
Date Founded: 2016
-
Employees: 51-200
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8011
Does something look wrong? Fix it. | View contact records from TENAYA THERAPEUTICS
Tenaya Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Tenaya Therapeutics
Answer: Tenaya Therapeutics's headquarters are located at 171 Oyster Pt BLVD, South San Francisco, California, 94080, United States
Answer: Tenaya Therapeutics's phone number is 51********
Answer: Tenaya Therapeutics's official website is https://tenayatherapeutics.com
Answer: Tenaya Therapeutics's revenue is Under $1 Million
Answer: Tenaya Therapeutics's SIC: 8011
Answer: Tenaya Therapeutics has 51-200 employees
Answer: Tenaya Therapeutics is in Biotechnology
Answer: Tenaya Therapeutics contact info: Phone number: 51******** Website: https://tenayatherapeutics.com
Answer: Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center. We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month